vimarsana.com
Home
Live Updates
Patients Less Likely to Experience Death at Academic and Hig
Patients Less Likely to Experience Death at Academic and Hig
Patients Less Likely to Experience Death at Academic and High-Volume Hospitals When Treated with Immunotherapy for Metastatic Cancers
A new study led by Yale Cancer Center researchers at Yale School of Medicine found that while the initiation of immunotherapy near the end of life has increased
Related Keywords
United States ,
James Clune ,
Howard Forman ,
Kelly Olino ,
Harriet Kluger ,
Alexander Frey ,
Elizabeth Prsic ,
Sajid Khan ,
Thuy Tran ,
Daniel Kerekes ,
Mario Sznol ,
Robert Becher ,
Yale Cancer Center ,
Yale School Of Medicine ,
Yale Department Of Surgery ,
Team Science At Yale Center ,
Tumors At Yale School Of Medicine ,
Yale School ,
Mixed Tumors ,
Steam Science ,
Yale Center ,
Yale Department ,